Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fangfei Peng"'
Autor:
Zhiyong Chen, Yingxian Wei, Likun Liang, Xu Wang, Fangfei Peng, Yiying Liang, Xin Huang, Kaiqi Yan, Yunxia Gao, Kangjing Li, Xiaoman Huang, Xinglu Jiang, Wenxia Chen
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
ObjectivesTo study the ability of theaflavin-3,3’-digallate (TF3)/ethanol solution to crosslink demineralized dentin collagen, resist collagenase digestion, and explore the potential mechanism.MethodsFully demineralized dentin blocks were prepared
Externí odkaz:
https://doaj.org/article/779e7aeac4ae4d7f99aa4359e07113bd
Autor:
Xiang Wang, Qing Xie, Yan Ji, Jiaxin Yang, Jiayan Shen, Fangfei Peng, Yongfeng Zhang, Feng Jiang, Xiangyin Kong, Wenzhe Ma, Dandan Liu, Leizhen Zheng, Chen Qing, Jing-Yu Lang
Publikováno v:
Cell Reports, Vol 42, Iss 1, Pp 111972- (2023)
Summary: KRAS is widely mutated in human cancers, resulting in unchecked tumor proliferation and metastasis, which makes identifying KRAS-targeting therapies a priority. Herein, we observe that mutant KRAS specifically promotes the formation of the E
Externí odkaz:
https://doaj.org/article/794e980aaf104344bc8d72ede062d54a
Autor:
Zhiyong Chen, Yingxian Wei, Likun Liang, Xu Wang, Fangfei Peng, Yiying Liang, Xin Huang, Kaiqi Yan, Yunxia Gao, Kangjing Li, Xiaoman Huang, Xinglu Jiang, Wenxia Chen
Publikováno v:
Frontiers in Bioengineering & Biotechnology; 2024, p01-15, 15p
Autor:
Yumin Han, Fangfei Peng, Yunqi Chang, Tingting Liu, Jiayan Shen, Zizhuo Chen, Qian Dong, Ping Zhou, Feng Jiang, Honggang Xiang, Hong Zhu, Chen Qing, Xiangyin Kong, Jian Ding, Jing-Yu Lang
Immune checkpoint therapy shows impressive and durable clinical responses in cancer patients, but the genetic determinants that enable cancer cells to respond to anti-PD-1 therapy are still elusive. Herein, we identified thatNIPBLdeficiency promotes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c8fc58e6cfdf808d0370e527d934f1e
https://doi.org/10.1101/2022.02.19.481125
https://doi.org/10.1101/2022.02.19.481125
Brca2 deficiency drives gastrointestinal tumor formation and is selectively inhibited by mitomycin C
Autor:
Heng Wang, Xiaomin Chen, Jing-Yu Lang, Yongfeng Zhang, Yumin Han, Tingting Liu, Fangfei Peng, Changxu Wang, Xiang Wang, Honggang Xiang, Yan Ji, Xiangyin Kong
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 9, Pp 1-13 (2020)
Cell Death and Disease, Vol 11, Iss 9, Pp 1-13 (2020)
BRCA2 is crucial for repairing DNA double-strand breaks with high fidelity, and loss of BRCA2 increases the risks of developing breast and ovarian cancers. Herein, we show that BRCA2 is inactively mutated in 10% of gastric and 7% of colorectal adenoc